A study on the immune response and safety of a vaccine against Herpes Zoster in adults aged 50 years and older in India

Trial Identifier: 214461
Sponsor: GlaxoSmithKline
Start Date: February 2022
Primary Completion Date: October 2022
Study Completion Date: December 2022
Condition: Other - Conditions

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
India Kanpur, India, 208002
India Mysore, India, 570004
India New Delhi, India, 110060
India Pune, India, 412216
India, Andhra Pradesh Visakhapatnam, Andhra Pradesh, India, N/A
India, Assam North Guwahati, Assam, India, 781031
India, Gujarat Ahmedabad, Gujarat, India, 380005
India, Maharashtra Mumbai, Maharashtra, India, N/A
India, Punjab Chandigarh, Punjab, India, 160012